Concepedia

Publication | Closed Access

Antenatal Treatment with Intravenous Immunoglobulin to Prevent Gestational Alloimmune Liver Disease: Comparative Effectiveness of 14-Week versus 18-Week Initiation

DOI

43

Citations

13

References

2017

Year

Peter F. Whitington, Susan Kelly, Sarah A. Taylor, Sara Nóbrega, Richard A. Schreiber, Étienne Sokal, Judith U. Hibbard
Fetal Diagnosis and Therapy

Abstract

Antenatal therapy with high-dose IVIG initiated at either 18 or 14 gestational weeks effectively prevents poor outcome of pregnancies at risk for GALD.

References

YearCitations

Page 1